Meeder Asset Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$46K	Buy	+2,036	New	+$45.2K	﹤0.01%	460
2025 Q3	–	Sell	-3,227	Closed	-$77.1K	–	910
2025 Q2	$77.1K	Buy	+3,227	New	+$81.3K	﹤0.01%	324
2022 Q4	–	Sell	-19	Closed	-$1K	–	1641
2022 Q3	$1K	Buy	19 +6	+46%	+$334	﹤0.01%	1992
2022 Q2	$1K	Buy	13 +4	+44%	+$262	﹤0.01%	2049
2022 Q1	$1K	Buy	+9	New	+$600	﹤0.01%	2227
2021 Q4	–	Sell	-1	Closed	–	–	2004
2021 Q3	$0	Buy	+1	New	+$58	﹤0.01%	2597
2020 Q2	–	Sell	-3,998	Closed	-$135K	–	2349
2020 Q1	$135K	Sell	3,998 -6,249	-61%	-$260K	0.01%	650
2019 Q4	$464K	Buy	10,247 +9,746	+1,945%	+$414K	0.03%	418
2019 Q3	$18K	Sell	501 -5,658	-92%	-$226K	﹤0.01%	1351
2019 Q2	$268K	Sell	6,159 -64	-1%	-$2.72K	0.02%	516
2019 Q1	$237K	Buy	6,223 +1,620	+35%	+$63.2K	0.02%	507
2018 Q4	$198K	Buy	4,603 +4,483	+3,736%	+$209K	0.02%	501
2018 Q3	$6K	Buy	120 +22	+22%	+$951	﹤0.01%	1299
2018 Q2	$3.14K	Hold	98	–	–	﹤0.01%	1346
2018 Q1	$3K	Buy	+98	New	+$3.49K	﹤0.01%	1330
2017 Q3	–	Sell	-59	Closed	-$3K	–	1728
2017 Q2	$3K	Sell	59 -233	-80%	-$10.8K	﹤0.01%	1332
2017 Q1	$13K	Sell	292 -298	-51%	-$12.9K	﹤0.01%	797
2016 Q4	$19K	Buy	+590	New	+$19.7K	﹤0.01%	666
2015 Q4	–	Sell	-500	Closed	-$21K	–	845
2015 Q3	$21K	Hold	500	–	–	﹤0.01%	647
2015 Q2	$35K	Hold	500	–	–	﹤0.01%	422
2015 Q1	$44K	Hold	500	–	–	﹤0.01%	459
2014 Q4	$44K	Hold	500	–	–	0.01%	408
2014 Q3	$48K	Sell	500 -200	-29%	-$19.5K	0.01%	315
2014 Q2	$64K	Hold	700	–	–	0.01%	281
2014 Q1	$49K	Hold	700	–	–	0.01%	286
2013 Q4	$40K	Hold	700	–	–	0.01%	303
2013 Q3	$34K	Hold	700	–	–	0.01%	286
2013 Q2	$20K	Buy	+700	New	+$20.3K	﹤0.01%	304